JP2003171291A - 乳房炎用粘膜予防剤 - Google Patents

乳房炎用粘膜予防剤

Info

Publication number
JP2003171291A
JP2003171291A JP30911699A JP30911699A JP2003171291A JP 2003171291 A JP2003171291 A JP 2003171291A JP 30911699 A JP30911699 A JP 30911699A JP 30911699 A JP30911699 A JP 30911699A JP 2003171291 A JP2003171291 A JP 2003171291A
Authority
JP
Japan
Prior art keywords
cells
cell
preparation
inactivated
mastitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP30911699A
Other languages
English (en)
Japanese (ja)
Inventor
Takuya Furumichi
琢也 古路
Toshikatsu Hayashi
俊克 林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Schering Plough Animal Health KK
Original Assignee
Takeda Schering Plough Animal Health KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Schering Plough Animal Health KK filed Critical Takeda Schering Plough Animal Health KK
Priority to JP30911699A priority Critical patent/JP2003171291A/ja
Priority to AU79564/00A priority patent/AU7956400A/en
Priority to PCT/JP2000/007445 priority patent/WO2001032205A1/fr
Publication of JP2003171291A publication Critical patent/JP2003171291A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP30911699A 1999-10-29 1999-10-29 乳房炎用粘膜予防剤 Pending JP2003171291A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP30911699A JP2003171291A (ja) 1999-10-29 1999-10-29 乳房炎用粘膜予防剤
AU79564/00A AU7956400A (en) 1999-10-29 2000-10-24 Mucosal preventives for mastitis
PCT/JP2000/007445 WO2001032205A1 (fr) 1999-10-29 2000-10-24 Preventifs muqueux contre la mastite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30911699A JP2003171291A (ja) 1999-10-29 1999-10-29 乳房炎用粘膜予防剤

Publications (1)

Publication Number Publication Date
JP2003171291A true JP2003171291A (ja) 2003-06-17

Family

ID=17989091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP30911699A Pending JP2003171291A (ja) 1999-10-29 1999-10-29 乳房炎用粘膜予防剤

Country Status (3)

Country Link
JP (1) JP2003171291A (fr)
AU (1) AU7956400A (fr)
WO (1) WO2001032205A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013055945A (ja) * 2004-08-17 2013-03-28 Hunter Immunology Ltd 経口不活化ワクチン及びそれを提供するための方法
WO2015093546A1 (fr) * 2013-12-18 2015-06-25 旭化成株式会社 Procédé pour détecter des bactéries du genre streptococcies dans le lait
WO2015093544A1 (fr) * 2013-12-18 2015-06-25 旭化成株式会社 Procédé de détection de staphylocoques dans le lait
WO2015093545A1 (fr) * 2013-12-18 2015-06-25 旭化成株式会社 Procédé de détection de bactéries coliformes dans le lait

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5114628B2 (ja) * 2005-02-25 2013-01-09 国立大学法人三重大学 リポソームワクチンの作製法
CN101378777A (zh) * 2006-02-07 2009-03-04 日本生物学的制剂有限公司 新型疫苗载体
JP2009286730A (ja) * 2008-05-29 2009-12-10 Nai Kk 新規乳房炎ワクチン
CN102294026A (zh) * 2010-11-17 2011-12-28 赤峰博恩药业有限公司 奶牛链球菌乳房炎灭活疫苗及其制备方法
CN102389568B (zh) * 2011-04-25 2014-02-19 通威股份有限公司 一种预防金鲳鱼溃疡病的疫苗
CN111387133B (zh) * 2020-02-25 2021-04-16 中国农业大学 一种肺炎克雷伯杆菌噬菌体抑制小鼠乳腺炎模型建立方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182555A (en) * 1967-10-16 1970-02-25 Saphar Lab Ltd An Anti-Mastitis Vaccine
IE51174B1 (en) * 1980-04-14 1986-10-29 Merck & Co Inc Group b streptococcal capsular polysaccharides
JPH0356426A (ja) * 1989-07-24 1991-03-12 Gifu Meneki Kenkyusho:Kk ウシ乳房炎予防および治療用抗体含有材料
TW448185B (en) * 1993-11-05 2001-08-01 Lilly Co Eli Vaccine design and production
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013055945A (ja) * 2004-08-17 2013-03-28 Hunter Immunology Ltd 経口不活化ワクチン及びそれを提供するための方法
WO2015093546A1 (fr) * 2013-12-18 2015-06-25 旭化成株式会社 Procédé pour détecter des bactéries du genre streptococcies dans le lait
WO2015093544A1 (fr) * 2013-12-18 2015-06-25 旭化成株式会社 Procédé de détection de staphylocoques dans le lait
WO2015093545A1 (fr) * 2013-12-18 2015-06-25 旭化成株式会社 Procédé de détection de bactéries coliformes dans le lait
JPWO2015093546A1 (ja) * 2013-12-18 2017-03-23 旭化成株式会社 乳汁中のストレプトコッカス属の菌を検出する方法
JPWO2015093545A1 (ja) * 2013-12-18 2017-03-23 旭化成株式会社 乳汁中の大腸菌群を検出する方法
JPWO2015093544A1 (ja) * 2013-12-18 2017-03-23 旭化成株式会社 乳汁中のブドウ球菌を検出する方法
US10139409B2 (en) 2013-12-18 2018-11-27 Asahi Kasei Kabushiki Kaisha Method for detecting Streptococcus bacterium contained in milk
US10151751B2 (en) 2013-12-18 2018-12-11 Asahi Kasei Kabushiki Kaisha Method for detecting Staphylococcus contained in milk
US10345299B2 (en) 2013-12-18 2019-07-09 Asahi Kasei Kabushiki Kaisha Method for detecting coliform bacteria contained in milk
US10527617B2 (en) 2013-12-18 2020-01-07 Asahi Kasei Kabushiki Kaisha Method for detecting Streptococcus bacterium contained in milk
US10527616B2 (en) 2013-12-18 2020-01-07 Asahi Kasei Kabushiki Kaisha Method for detecting Staphylococcus contained in milk
US10732179B2 (en) 2013-12-18 2020-08-04 Asahi Kasei Kabushiki Kaisha Method for detecting Staphylococcus contained in milk
US10908160B2 (en) 2013-12-18 2021-02-02 Asahi Kasei Kabushiki Kaisha Method for detecting Streptococcus bacterium contained in milk
US11567076B2 (en) 2013-12-18 2023-01-31 Asahi Kasei Kabushiki Kaisha Method for detecting coliform bacteria contained in milk

Also Published As

Publication number Publication date
WO2001032205A1 (fr) 2001-05-10
AU7956400A (en) 2001-05-14

Similar Documents

Publication Publication Date Title
Husband Novel vaccination strategies for the control of mucosal infection
US5674495A (en) Alginate-based vaccine compositions
US20120135039A1 (en) Oral Vaccines for Producing Mucosal Immunity
TWI359666B (fr)
KR101124363B1 (ko) 면역조절곤란증을 포함하는 질병을 치료하기 위한 그람양성균 제제
US20020009463A1 (en) Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
JP2000507608A (ja) ワクチン結合物を用いて免疫活性を産生する方法
JP2003171291A (ja) 乳房炎用粘膜予防剤
JP2007538090A (ja) 伝達因子封入組成物および使用方法
TWI334355B (en) Method for preparing an orally administrable formulation for controlled release and orally administrable formulation
WO1995031184A1 (fr) Liberation de molecules bioactives
Liao et al. Oral immunization using formalin-inactivated Actinobacillus pleuropneumoniae antigens entrapped in microspheres with aqueous dispersion polymers prepared using a co-spray drying process
EP3768820B1 (fr) Francisella tularensis lyophilisation de souches vaccinales vivante contre
Suckow et al. Oral immunization of rabbits against Pasteurella multocida with an alginate microsphere delivery system
JP4714167B2 (ja) エリシペロスリクス・ルシオパシエ抗原及びワクチン組成物
JP3649787B2 (ja) 魚類の腸球菌感染症用予防剤およびその用途
JPH0356426A (ja) ウシ乳房炎予防および治療用抗体含有材料
RU2815387C1 (ru) Штамм бактерий Corynebacterium pseudotuberculosis, предназначенный для получения моно- или поливалентных иммуногенных композиций, направленных на специфическую профилактику казеозного лимфаденита (псевдотуберкулеза) мелкого рогатого скота
RU2158587C1 (ru) Антибактериальное средство для лечения заболеваний сельскохозяйственных животных и птиц, способ профилактики и лечения цыплят при заболеваниях бактериальной этиологии, способ лечения респираторной болезни телят бактериальной этиологии, способ профилактики туберкулеза у крупного рогатого скота
US20230364213A1 (en) Method for lyophilizing live vaccine strains of francisella tularensis
KR20220061072A (ko) 돼지 흉막폐렴균 (1형, 2형, 5형, 7형, 10형, 12형 및 15형) 불활화 사균체를 포함한 돼지 흉막폐렴 백신 조성물
WO2024088138A1 (fr) Vaccin oral inactivé perméabilisé par une membrane plasmatique
US8524250B2 (en) Carrier
JP2001342147A (ja) Ｍ細胞取り込み制御によるヨーネ病感染の予防方法およびそのワクチン
Șandru et al. An emerging episode of clostridial disease in imported dairy cattle.